Today the process is largely manual, but that is changing. The invention, rapid manufacturing and distribution of the COVID-19 vaccine demonstrates exactly how fast the life sciences treatment development pipeline can move when the right factors are in play. Biopharmaceutical treatments commonly take upwards of 15 years to develop, but the COVID vaccine was created and manufactured in only eight months.
Emerson’s President of the Process Systems and Solutions business Nathan Pettus shares his thoughts in this article in IndustryWeek magazine on how having the right technology, open standards and operational buy-in can reduce the technology transfer process to a fraction of the time it takes today.
Latest News
Emerson Partners with MSTelcom
MSTelcom has chosen Emerson to provide the company’s full automation portfolio for energy and industrial customers in Angola, further advancing...
New Emerson Pneumatic Valves Provide Greater Automation Flexibility, Optimized Flow
The AVENTICS XV valve series features multiple interoperable valve sizes and higher flow rates in a compact design
Emerson Enhances Control System Software for Seamless Data Integration, Improved Operational...
DeltaV distributed control system update features expanded connectivity via Ethernet-based protocols and streamlined state-based control execution
